The Defend Trade Secrets Act has been passed 87-0 in the US Senate. It would allow federal actions in response to the misappropriation of trade secrets, but it is not clear how big an impact it would have after some of the more controversial provisions were scaled back by a Senate committee and with the House of Representatives yet to vote on the bill
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works